Sanofi, Regeneron experimental drug lowers risk of stroke, heart attack

September 2, 2014 2:12 AM

18 0

Sanofi, Regeneron experimental drug lowers risk of stroke, heart attack

Heart health is a big concern for many people. With the coming of alirocumab, Sanofi and Regeneron might just herald the coming of a second life for millions of patients.(Photo : Louise Docker)

Heart health is a big concern for many people. With the coming of alirocumab, Sanofi and Regeneron might just herald the coming of a second life for millions of patients.

Also read: Half a million call for reversal of decision to strip Uber’s London licence

Read more

To category page

Loading...